Laboratorios Hipra SA: COVID-19 vaccine HIPRA

Vaccine Type: Protein Subunit

This vaccine may also be referred to as HIPRA SARS-CoV-2, PHH-1V

Vaccine Trial & Approval Tracker

This vaccine has reached Phase 3 trials.

About Trial Phases

Phase 1: 1 Trial

Phase 2: 6 Trials

Phase 3: 3 Trials


This vaccine is not yet approved.

Registered Trials